Try to Avoid PPIs With New Hep C Med Epclusa

Please see the October 2016 FDA advisory about the risk of Hepatitis B reactivation in some patients being treated for Hepatitis C.

Epclusa (ep-KLOO-suh, sofosbuvir/velpatasvir) will further simplify hepatitis C treatment.

So far, other recent hep C meds (Harvoni, Zepatier, etc) can only be used for certain hep C genotypes...and treatment duration varies.

But Epclusa is a one-tab, once-daily med that can be used for ANY hep C genotype...and patients use just a 12-week course.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote